Evidence map›Paper›PMID 30273371›Full record

ArticlePloS one2018

The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer.

Danuta Gąsior-Perczak, Iwona Pałyga, Monika Szymonek, Artur Kowalik, Agnieszka Walczyk, Janusz Kopczyński, Katarzyna Lizis-Kolus, Tomasz Trybek, Estera Mikina, Dorota Szyska-Skrobot and 8 more

Abstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Analysis of Body Mass Index and Clinicopathological Factors in Patients with Papillary Thyroid Carcinoma.Diabetes, metabolic syndrome and obesity : targets and therapy · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Incidence of theCancers · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Danuta Gąsior-PerczakEndocrinology Clinic, Holycross Cancer Centre, Kielce, Poland.ORCID 0000-0003-0936-4890
Iwona PałygaEndocrinology Clinic, Holycross Cancer Centre, Kielce, Poland.
Monika SzymonekEndocrinology Clinic, Holycross Cancer Centre, Kielce, Poland.
Artur KowalikDepartment of Molecular Diagnostics, Holycross Cancer Centre, Kielce, Poland.ORCID 0000-0002-3718-999X
Agnieszka WalczykEndocrinology Clinic, Holycross Cancer Centre, Kielce, Poland.
Janusz KopczyńskiDepartment of Surgical Pathology, Holycross Cancer Centre, Kielce, Poland.
Katarzyna Lizis-KolusEndocrinology Clinic, Holycross Cancer Centre, Kielce, Poland.
Tomasz TrybekEndocrinology Clinic, Holycross Cancer Centre, Kielce, Poland.
Estera MikinaEndocrinology Clinic, Holycross Cancer Centre, Kielce, Poland.
Dorota Szyska-SkrobotEndocrinology Clinic, Holycross Cancer Centre, Kielce, Poland.
Klaudia Gadawska-JuszczykEndocrinology Clinic, Holycross Cancer Centre, Kielce, Poland.
Stefan HurejEndocrinology Clinic, Holycross Cancer Centre, Kielce, Poland.
Artur SzczodryEndocrinology Clinic, Holycross Cancer Centre, Kielce, Poland.
Anna SłuszniakLaboratory of Tumor Markers, Holycross Cancer Centre, Kielce, Poland.
Janusz SłuszniakDepartment of Surgical Oncology, Holycross Cancer Centre, Kielce, Poland.
Ryszard MężykCancer Epidemiology, Holycross Cancer Centre, Kielce, Poland.
Stanisław GóźdźOncology Clinic, Holycross Cancer Centre, Kielce, Poland.
Aldona KowalskaEndocrinology Clinic, Holycross Cancer Centre, Kielce, Poland.ORCID 0000-0001-5647-5898

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionObesity is a serious health problem worldwide, particularly in developed countries. It is a risk factor for many diseases, including thyroid cancer. The relationship between obesity and prognostic factors of thyroid cancer is unclear.

aimsWe sought to ascertain the relationship between body mass index (BMI) and clinicopathological features increasing the risk of poor clinical course, treatment response, and clinical outcome in patients with differentiated thyroid cancer (DTC). SUBJECTS &

methodsThe study included 1181 patients with DTC (88% women and 12% men) treated at a single center from 2000 to 2016. BMI before surgery and aggressive clinicopathological features, according to the American Thyroid Initial Risk stratification system, were analyzed. The relationship between BMI and initial risk, treatment response, and final status of the disease was evaluated, incorporating the revised 2015 American Thyroid Association guidelines and the 8th edition of the American Joint Committee on Cancer/Tumor-Node-Metastasis (AJCC/TNM) staging system. Patients were stratified according to the World Health Organization classification of BMI. Statistical analysis was performed using univariate and multivariate logistic regression analysis.

resultsMedian follow-up was 7.7 years (1-16 years). There were no significant associations between BMI and extrathyroidal extension (microscopic and gross), cervical lymph node metastasis, or distant metastasis in univariate and multivariate analyses. BMI did not affect initial risk, treatment response or disease outcome. Obesity was more prevalent in men (p = 0.035) and in patients ≥55 years old (p = 0.001). There was no statistically significant relationship between BMI and more advanced TNM stage in patients ≤55 years old (stage I vs. stage II) (p = 0.266) or in patients >55 years old (stage I-II vs. III-IV) (p = 0.877).

conclusionsObesity is not associated with more aggressive clinicopathological features of thyroid cancer. Obesity is not a risk factor for progression to more advanced stages of disease, nor is it a prognostic factor for poorer treatment response and clinical outcome.

Indexed as

Body Mass IndexAdultAgedDisease ProgressionFemaleHumansKaplan-Meier EstimateMaleMiddle AgedObesityPolandPrognosisRetrospective StudiesRisk FactorsThyroid Cancer, PapillaryThyroid Neoplasms

Identifiers

PMID30273371
PMCPMC6166948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.